Continuing advanced therapies before elective Crohn's surgery may reduce serious complications
Patients with Crohn's disease who continue advanced therapies, including biologics and small-molecule drugs, in the months before elective colorectal surgery may have a lower risk of two postoperative complications: anastomotic leak and organ space surgical site infection, according to a study published in the Journal of the American College of Surgeons.
Read original article on Medical Xpress - latest medical and health news stories →